Ye Xu

Ye Xu

Auto-generated profile, based on publicly available information

Ye Xu

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2022 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
SYSonghua Yang
Songhua Yang
SHShixiong Huang
Shixiong Huang
XYXu Ye
Xu Ye
KXKun Xiong
Kun Xiong
BZBiao Zeng
Biao Zeng
YSYingrui Shi
Yingrui Shi
Background: Radiotherapy is an important treatment for patients with stage III/IV non-small cell lung cancer (NSCLC), and due to its high incidence of radiation pneumonitis, it is essential to identify high-risk people as early as possible. The present work investigates the value of the application of different phase data throughout the radiotherapy process in analyzing risk of grade ≥ 2 radiation pneumonitis in stage III/IV NSCLC. Furthermore, the phase data fusion was gradually performed with the radiotherapy timeline to develop a risk assessment model. Methods: This study retrospectively collected data from 91 stage III/IV NSCLC cases treated with Volumetric modulated arc therapy (VMAT). Patient data were collected according to the radiotherapy timeline for four phases: clinical characteristics, radiomics features, radiation dosimetry parameters, and hematological indexes during treatment. Risk assessment models for single-phase and stepwise fusion phases were established according to logistic regression. In addition, a nomogram of the final fusion phase model and risk classification system was generated. Receiver operating characteristic (ROC), decision curve, and calibration curve analysis were conducted to internally validate the nomogram to analyze its discrimination. Results: Smoking status, PTV and lung radiomics feature, lung and esophageal dosimetry parameters, and platelets at the third week of radiotherapy were independent risk factors for the four single-phase models. The ROC result analysis of the risk assessment models created by stepwise phase fusion were: (area under curve [AUC]: 0.67,95% confidence interval [CI]: 0.52–0.81), (AUC: 0.82,95%CI: 0.70–0.94), (AUC: 0.90,95%CI: 0.80–1.00), and (AUC:0.90,95%CI: 0.80–1.00), respectively. The nomogram based on the final fusion phase model was validated using calibration curve analysis and decision curve analysis, demonstrating good consistency and clinical utility. The nomogram-based risk classification system could correctly classify cases into three diverse risk groups: low-(ratio:3.6%; 0 < score < 135), intermediate-(ratio:30.7%, 135 < score < 160) and high-risk group (ratio:80.0%, score > 160). Conclusions: In our study, the risk assessment model makes it easy for physicians to assess the risk of grade ≥ 2 radiation pneumonitis at various phases in the radiotherapy process, and the risk classification system and nomogram identify the patient’s risk level after completion of radiation therapy.

3 April 2023
Verified
Other
Open access
QLQingguo Li
Qingguo Li
YQYi Qin
Yi Qin
WPWei Ping
Wei Ping
PLPeng Lian
Peng Lian
LQLi Qi
Li Qi
SCSanjun Cai
Sanjun Cai
Endogenous expression level of Gas1 in six colon cancer cells demonstrated by Western blot (A) and RT-PCR (B).

31 March 2023
Verified
Other
Open access
YXYe Xu
Ye Xu
QXQinghua Xu
Qinghua Xu
LYLi Yang
Li Yang
XYXun Ye
Xun Ye
FLFang Liu
Fang Liu
XDXiang Du
Xiang Du
PDF file - 58K, The table list primer sequences for 18 signature genes and 3 reference genes.

31 March 2023
Verified
Other
Open access
YXYe Xu
Ye Xu
QXQinghua Xu
Qinghua Xu
LYLi Yang
Li Yang
XYXun Ye
Xun Ye
FLFang Liu
Fang Liu
XDXiang Du
Xiang Du
PDF file - 65K, Association between samples' characteristics and signature prediction outcomes.

31 March 2023
Verified
Other
Open access
YXYe Xu
Ye Xu
QXQinghua Xu
Qinghua Xu
LYLi Yang
Li Yang
XYXun Ye
Xun Ye
FLFang Liu
Fang Liu
XDXiang Du
Xiang Du
PDF file - 70K, Signature genes enriched in Gene Ontology and KEGG pathway.

31 March 2023
Verified
Other
Open access
YXYe Xu
Ye Xu
QXQinghua Xu
Qinghua Xu
LYLi Yang
Li Yang
XYXun Ye
Xun Ye
FLFang Liu
Fang Liu
XDXiang Du
Xiang Du
PDF file - 151K, On the heat map, red colors indicate genes upregulated and green colors indicate genes downregulated. Among the 263 genes, 179 were up-regulated and 84 were down-regulated in the cancer patients, respectively. On the hierarchical clustering diagram, green bars represent controls and red bars represent CRC patients. Two hundred samples appeared to be distributed into two major separate clusters with few overlaps, revealing distinct gene expression patterns between the CRC group and the Control group.